News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2020 Shelley Wood December 31, 2020
News Daily News FDA Passes on Inclisiran, Citing Manufacturing Site Problems Shelley Wood December 23, 2020
News Features Funding the Future: How Industry Support for CV Trials Could Evolve Michael O'Riordan December 17, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Industry News MagicTouch SCB Granted 'Breakthrough Device Designation' for the treatment of Small Coronary Artery Lesions. December 16, 2020
News Daily News FDA: Penumbra JET 7 Clot Retrievers Recalled Following Deaths, Injuries Shelley Wood December 16, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Daily News Inclisiran Approved in Europe for Lowering LDL Cholesterol Michael O'Riordan December 11, 2020
News Daily News FDA Reminder: Yearly, Lifelong Surveillance Needed for Endologix AAA Grafts L.A. McKeown December 04, 2020
News Conference News VIVA 2020 As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice L.A. McKeown November 27, 2020
News Daily News Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much Michael O'Riordan November 26, 2020
News Daily News Lotus Edge TAVR Device Recalled and Discontinued Worldwide Michael O'Riordan November 18, 2020
News Conference News AHA 2020 Rilonacept Prevents Recurrent Pericarditis: RHAPSODY Shelley Wood November 17, 2020
News Industry News Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt November 17, 2020
News Features As US Cardiologists Mull a Biden Presidency, COVID-19 Trumps All Todd Neale November 13, 2020
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020